Combining active ingredients to treat depression in the wake of COVID-19. | Lancet Psychiatry;9(3): 190-191, 2022 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Combining active ingredients to treat depression in the wake of COVID-19.

Abas, Melanie A.

Abas MA; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK. Electronic address: melanie.abas@kcl.ac.uk.

Lancet Psychiatry ; 9(3): 190-191, 2022 03.

Article in English | MEDLINE | ID: covidwho-1713045

Subject(s)

COVID-19; Depression/therapy; Depressive Disorder/therapy; Patient Education as Topic; Psychotherapy; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psychotherapy / Patient Education as Topic / Depression / Depressive Disorder / COVID-19 Limits: Humans Language: English Journal: Lancet Psychiatry Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psychotherapy / Patient Education as Topic / Depression / Depressive Disorder / COVID-19 Limits: Humans Language: English Journal: Lancet Psychiatry Year: 2022 Document Type: Article